Arch Pharmalabs
BSE: 524729|ISIN: INE182F01017|SECTOR: Pharmaceuticals
Arch Pharmalabs is not traded in the last 30 days
Arch Pharmalabs is not listed on NSE
Yearly Results of Arch Pharmalabs |
------------------- in Rs. Cr. ------------------- |
 | ||||||||||
|
||||||||||
| Mar '05 | Mar '04 | Mar '98 | Mar '97 | Mar '95 | ||||||
|
||||||||||
| Sales Turnover | 155.68 | 96.46 | 2.62 | 8.84 | 5.01 | |||||
| Other Income | 0.26 | 0.31 | 3.00 | 0.29 | 0.74 | |||||
| Total Income | 155.93 | 96.77 | 5.63 | 9.13 | 5.75 | |||||
| Total Expenses | 127.16 | 79.36 | 4.78 | 7.64 | 4.90 | |||||
| Operating Profit | 28.52 | 17.10 | -2.16 | 1.20 | 0.11 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 28.78 | 17.41 | 0.84 | 1.49 | 0.85 | |||||
| Interest | 9.27 | 6.19 | 2.45 | 2.25 | 0.16 | |||||
| PBDT | 19.52 | 11.23 | -1.61 | -0.76 | 0.69 | |||||
| Depreciation | 3.32 | 1.10 | 0.66 | 0.67 | 0.04 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 16.20 | 10.13 | -2.27 | -1.43 | 0.65 | |||||
| Tax | 5.00 | 1.20 | -- | -- | -- | |||||
| Net Profit | 11.20 | 8.93 | -2.27 | -1.43 | 0.65 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 8.50 | 10.23 | -- | -- | 0.80 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 13.17 | 8.73 | 8.10 | 8.10 | 8.10 | |||||
| Reserves | -- | -- | -- | -- | 0.65 | |||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Dion Global Solutions Limited | ||||||||||
| Explore Arch Pharmalabs connections | ||||||||||
| ||||||||||
Results of Arch Pharmalabs
- News
- Results
- Estimates
- Analysis
No news.
Results of Pharmaceuticals Sector
- News
- Results
- Estimates
- Analysis
Quick Links for archpharmalabs
|
Related Searches
archpharmalabs Stock Price, Arch%20Pharmalabs Stock Quote, Arch%20Pharmalabs Results , Arch%20Pharmalabs News ..
More »
Follow moneycontrol.com
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News |
Markets |
IPO |
Technicals |
Mutual Fund |
Commodities |
Best Portfolio Manager |
Bse Sensex |
Bombay Stock Exchange |
Share Market Live |
Recession 2011 |
Commodities Price |
Silver Price/Rate in India |
Gold Price/Rate in India |
Crude Oil |
USD to INR |
National Stock Exchange |
Bank Fixed Deposits |
Company Fixed Deposits |
Small Savings Schemes |
Property rates in India |
| Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
Bigg Boss Season 5
| History India | Davos
| Uninor | Niko Resources | Vodafone Essar | Aurobindo Pharma | DLF | Search Engines | Namma Metro | Reliance Industries | Maruti Suzuki | Tata Steel
| Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
Bigg Boss Season 5
| History India | Davos
| Uninor | Niko Resources | Vodafone Essar | Aurobindo Pharma | DLF | Search Engines | Namma Metro | Reliance Industries | Maruti Suzuki | Tata Steel
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.